nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—KIT—thymus cancer	0.675	1	CbGaD
Pazopanib—Pruritus generalised—Octreotide—thymus cancer	0.0059	0.0659	CcSEcCtD
Pazopanib—Sinus bradycardia—Octreotide—thymus cancer	0.00401	0.0448	CcSEcCtD
Pazopanib—Hypothyroidism—Octreotide—thymus cancer	0.00307	0.0342	CcSEcCtD
Pazopanib—Nail disorder—Octreotide—thymus cancer	0.00304	0.0339	CcSEcCtD
Pazopanib—Metrorrhagia—Octreotide—thymus cancer	0.00276	0.0308	CcSEcCtD
Pazopanib—Endocrine disorder—Octreotide—thymus cancer	0.00238	0.0265	CcSEcCtD
Pazopanib—Neoplasm malignant—Octreotide—thymus cancer	0.00231	0.0257	CcSEcCtD
Pazopanib—Rectal haemorrhage—Octreotide—thymus cancer	0.00218	0.0243	CcSEcCtD
Pazopanib—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00217	0.0242	CcSEcCtD
Pazopanib—Oropharyngeal pain—Octreotide—thymus cancer	0.00217	0.0242	CcSEcCtD
Pazopanib—MAP3K9—epithelium—thymus cancer	0.00206	0.0149	CbGeAlD
Pazopanib—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00197	0.022	CcSEcCtD
Pazopanib—ITK—hematopoietic system—thymus cancer	0.00186	0.0134	CbGeAlD
Pazopanib—Mouth ulceration—Octreotide—thymus cancer	0.00178	0.0199	CcSEcCtD
Pazopanib—TAOK1—hematopoietic system—thymus cancer	0.00169	0.0122	CbGeAlD
Pazopanib—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00164	0.0183	CcSEcCtD
Pazopanib—SH2B3—hematopoietic system—thymus cancer	0.00159	0.0115	CbGeAlD
Pazopanib—Cardiac failure congestive—Octreotide—thymus cancer	0.00158	0.0176	CcSEcCtD
Pazopanib—Hot flush—Octreotide—thymus cancer	0.00153	0.0171	CcSEcCtD
Pazopanib—Menopausal symptoms—Octreotide—thymus cancer	0.00151	0.0169	CcSEcCtD
Pazopanib—MAP3K9—thyroid gland—thymus cancer	0.00144	0.0104	CbGeAlD
Pazopanib—PLK4—hematopoietic system—thymus cancer	0.00143	0.0104	CbGeAlD
Pazopanib—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00143	0.016	CcSEcCtD
Pazopanib—STK16—hematopoietic system—thymus cancer	0.00135	0.00978	CbGeAlD
Pazopanib—LYN—hematopoietic system—thymus cancer	0.00134	0.00967	CbGeAlD
Pazopanib—FGFR3—hematopoietic system—thymus cancer	0.00133	0.00962	CbGeAlD
Pazopanib—Dehydration—Octreotide—thymus cancer	0.00133	0.0148	CcSEcCtD
Pazopanib—Dry skin—Octreotide—thymus cancer	0.00131	0.0146	CcSEcCtD
Pazopanib—MAP3K9—lung—thymus cancer	0.00131	0.00945	CbGeAlD
Pazopanib—ITK—lymphoid tissue—thymus cancer	0.00131	0.00945	CbGeAlD
Pazopanib—Abdominal pain upper—Octreotide—thymus cancer	0.00131	0.0146	CcSEcCtD
Pazopanib—Nasopharyngitis—Octreotide—thymus cancer	0.00128	0.0143	CcSEcCtD
Pazopanib—TAOK1—pituitary gland—thymus cancer	0.00125	0.00906	CbGeAlD
Pazopanib—Abdominal distension—Octreotide—thymus cancer	0.00124	0.0139	CcSEcCtD
Pazopanib—FGF1—neck—thymus cancer	0.00124	0.00896	CbGeAlD
Pazopanib—FGFR3—epithelium—thymus cancer	0.00122	0.0088	CbGeAlD
Pazopanib—Pancreatitis—Octreotide—thymus cancer	0.00121	0.0135	CcSEcCtD
Pazopanib—SH2B3—cardiac atrium—thymus cancer	0.00121	0.00873	CbGeAlD
Pazopanib—BMPR1B—epithelium—thymus cancer	0.00121	0.00871	CbGeAlD
Pazopanib—ITK—bone marrow—thymus cancer	0.00119	0.0086	CbGeAlD
Pazopanib—ITK—thyroid gland—thymus cancer	0.00119	0.00858	CbGeAlD
Pazopanib—SH2B3—pituitary gland—thymus cancer	0.00118	0.00853	CbGeAlD
Pazopanib—FGFR2—neck—thymus cancer	0.00117	0.00846	CbGeAlD
Pazopanib—LIMK2—hematopoietic system—thymus cancer	0.00116	0.00836	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—thymus cancer	0.00112	0.00809	CbGeAlD
Pazopanib—Weight decreased—Octreotide—thymus cancer	0.00112	0.0125	CcSEcCtD
Pazopanib—FLT1—neck—thymus cancer	0.00109	0.00784	CbGeAlD
Pazopanib—TAOK1—bone marrow—thymus cancer	0.00108	0.00783	CbGeAlD
Pazopanib—TAOK1—thyroid gland—thymus cancer	0.00108	0.00781	CbGeAlD
Pazopanib—ITK—lung—thymus cancer	0.00108	0.00779	CbGeAlD
Pazopanib—Jaundice—Octreotide—thymus cancer	0.00107	0.012	CcSEcCtD
Pazopanib—Haematuria—Octreotide—thymus cancer	0.00105	0.0117	CcSEcCtD
Pazopanib—Hepatobiliary disease—Octreotide—thymus cancer	0.00104	0.0116	CcSEcCtD
Pazopanib—FLT4—hematopoietic system—thymus cancer	0.00104	0.00751	CbGeAlD
Pazopanib—Epistaxis—Octreotide—thymus cancer	0.00104	0.0116	CcSEcCtD
Pazopanib—SH2B3—bone marrow—thymus cancer	0.00102	0.00737	CbGeAlD
Pazopanib—SH2B3—thyroid gland—thymus cancer	0.00102	0.00735	CbGeAlD
Pazopanib—RIOK2—cardiac atrium—thymus cancer	0.00101	0.00731	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—thymus cancer	0.00101	0.00729	CbGeAlD
Pazopanib—Bradycardia—Octreotide—thymus cancer	0.00101	0.0112	CcSEcCtD
Pazopanib—STK16—pituitary gland—thymus cancer	0.001	0.00725	CbGeAlD
Pazopanib—AURKC—thyroid gland—thymus cancer	0.001	0.00724	CbGeAlD
Pazopanib—RIOK2—pituitary gland—thymus cancer	0.000988	0.00714	CbGeAlD
Pazopanib—Hypoaesthesia—Octreotide—thymus cancer	0.000984	0.011	CcSEcCtD
Pazopanib—TAOK1—lung—thymus cancer	0.000982	0.00709	CbGeAlD
Pazopanib—MAP3K2—hematopoietic system—thymus cancer	0.00098	0.00708	CbGeAlD
Pazopanib—Oedema peripheral—Octreotide—thymus cancer	0.000974	0.0109	CcSEcCtD
Pazopanib—STK16—lymphoid tissue—thymus cancer	0.000952	0.00688	CbGeAlD
Pazopanib—FLT4—epithelium—thymus cancer	0.00095	0.00687	CbGeAlD
Pazopanib—LYN—lymphoid tissue—thymus cancer	0.000942	0.00681	CbGeAlD
Pazopanib—SH2B3—lung—thymus cancer	0.000924	0.00668	CbGeAlD
Pazopanib—FGF1—hematopoietic system—thymus cancer	0.000923	0.00667	CbGeAlD
Pazopanib—PLK4—bone marrow—thymus cancer	0.000918	0.00664	CbGeAlD
Pazopanib—Flushing—Octreotide—thymus cancer	0.000918	0.0102	CcSEcCtD
Pazopanib—Cardiac disorder—Octreotide—thymus cancer	0.000918	0.0102	CcSEcCtD
Pazopanib—KDR—neck—thymus cancer	0.000918	0.00663	CbGeAlD
Pazopanib—PI4KB—cardiac atrium—thymus cancer	0.000894	0.00646	CbGeAlD
Pazopanib—MAP3K9—lymph node—thymus cancer	0.000894	0.00646	CbGeAlD
Pazopanib—STK36—pituitary gland—thymus cancer	0.000887	0.00641	CbGeAlD
Pazopanib—PI4KB—pituitary gland—thymus cancer	0.000874	0.00631	CbGeAlD
Pazopanib—Alopecia—Octreotide—thymus cancer	0.000874	0.00975	CcSEcCtD
Pazopanib—FGFR2—hematopoietic system—thymus cancer	0.000872	0.0063	CbGeAlD
Pazopanib—Mental disorder—Octreotide—thymus cancer	0.000866	0.00967	CcSEcCtD
Pazopanib—STK16—thyroid gland—thymus cancer	0.000865	0.00625	CbGeAlD
Pazopanib—Erythema—Octreotide—thymus cancer	0.000861	0.00961	CcSEcCtD
Pazopanib—Malnutrition—Octreotide—thymus cancer	0.000861	0.00961	CcSEcCtD
Pazopanib—LIMK2—pituitary gland—thymus cancer	0.000858	0.0062	CbGeAlD
Pazopanib—RIOK2—bone marrow—thymus cancer	0.000854	0.00617	CbGeAlD
Pazopanib—RIOK2—thyroid gland—thymus cancer	0.000852	0.00615	CbGeAlD
Pazopanib—Flatulence—Octreotide—thymus cancer	0.000848	0.00947	CcSEcCtD
Pazopanib—FGF1—epithelium—thymus cancer	0.000844	0.0061	CbGeAlD
Pazopanib—BMPR1B—thyroid gland—thymus cancer	0.000843	0.00609	CbGeAlD
Pazopanib—PLK4—lung—thymus cancer	0.000832	0.00601	CbGeAlD
Pazopanib—Muscle spasms—Octreotide—thymus cancer	0.000828	0.00924	CcSEcCtD
Pazopanib—LIMK2—lymphoid tissue—thymus cancer	0.000814	0.00588	CbGeAlD
Pazopanib—KIT—neck—thymus cancer	0.000813	0.00588	CbGeAlD
Pazopanib—Vision blurred—Octreotide—thymus cancer	0.000811	0.00906	CcSEcCtD
Pazopanib—FLT1—hematopoietic system—thymus cancer	0.000808	0.00584	CbGeAlD
Pazopanib—FGFR2—epithelium—thymus cancer	0.000797	0.00576	CbGeAlD
Pazopanib—Anaemia—Octreotide—thymus cancer	0.000796	0.00888	CcSEcCtD
Pazopanib—PDGFRB—neck—thymus cancer	0.000794	0.00574	CbGeAlD
Pazopanib—STK16—lung—thymus cancer	0.000786	0.00568	CbGeAlD
Pazopanib—PIP4K2C—cardiac atrium—thymus cancer	0.000785	0.00567	CbGeAlD
Pazopanib—FGFR1—cardiac atrium—thymus cancer	0.000779	0.00563	CbGeAlD
Pazopanib—RIOK2—lung—thymus cancer	0.000773	0.00559	CbGeAlD
Pazopanib—FGFR3—lung—thymus cancer	0.000773	0.00559	CbGeAlD
Pazopanib—Syncope—Octreotide—thymus cancer	0.000772	0.00862	CcSEcCtD
Pazopanib—PIP4K2C—pituitary gland—thymus cancer	0.000767	0.00554	CbGeAlD
Pazopanib—BMPR1B—lung—thymus cancer	0.000766	0.00553	CbGeAlD
Pazopanib—MAP3K19—lung—thymus cancer	0.000766	0.00553	CbGeAlD
Pazopanib—STK36—thyroid gland—thymus cancer	0.000765	0.00553	CbGeAlD
Pazopanib—STK10—hematopoietic system—thymus cancer	0.000765	0.00553	CbGeAlD
Pazopanib—TAOK3—hematopoietic system—thymus cancer	0.000762	0.00551	CbGeAlD
Pazopanib—FGFR1—pituitary gland—thymus cancer	0.000761	0.0055	CbGeAlD
Pazopanib—PDGFRA—hematopoietic system—thymus cancer	0.000757	0.00547	CbGeAlD
Pazopanib—Loss of consciousness—Octreotide—thymus cancer	0.000757	0.00845	CcSEcCtD
Pazopanib—PI4KB—bone marrow—thymus cancer	0.000755	0.00546	CbGeAlD
Pazopanib—PI4KB—thyroid gland—thymus cancer	0.000753	0.00544	CbGeAlD
Pazopanib—Cough—Octreotide—thymus cancer	0.000751	0.00839	CcSEcCtD
Pazopanib—Hypertension—Octreotide—thymus cancer	0.000743	0.0083	CcSEcCtD
Pazopanib—LIMK2—thyroid gland—thymus cancer	0.00074	0.00534	CbGeAlD
Pazopanib—FLT1—epithelium—thymus cancer	0.000739	0.00534	CbGeAlD
Pazopanib—ITK—lymph node—thymus cancer	0.000737	0.00533	CbGeAlD
Pazopanib—Arthralgia—Octreotide—thymus cancer	0.000733	0.00818	CcSEcCtD
Pazopanib—Myalgia—Octreotide—thymus cancer	0.000733	0.00818	CcSEcCtD
Pazopanib—Chest pain—Octreotide—thymus cancer	0.000733	0.00818	CcSEcCtD
Pazopanib—FLT4—lymphoid tissue—thymus cancer	0.000732	0.00529	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.000728	0.00813	CcSEcCtD
Pazopanib—UGT1A1—hematopoietic system—thymus cancer	0.000722	0.00522	CbGeAlD
Pazopanib—Dry mouth—Octreotide—thymus cancer	0.000717	0.008	CcSEcCtD
Pazopanib—Oedema—Octreotide—thymus cancer	0.000703	0.00784	CcSEcCtD
Pazopanib—FGF1—cardiac atrium—thymus cancer	0.000701	0.00507	CbGeAlD
Pazopanib—Infection—Octreotide—thymus cancer	0.000698	0.00779	CcSEcCtD
Pazopanib—STK36—lung—thymus cancer	0.000695	0.00502	CbGeAlD
Pazopanib—Shock—Octreotide—thymus cancer	0.000691	0.00772	CcSEcCtD
Pazopanib—MAP3K2—lymphoid tissue—thymus cancer	0.00069	0.00499	CbGeAlD
Pazopanib—Nervous system disorder—Octreotide—thymus cancer	0.000689	0.00769	CcSEcCtD
Pazopanib—Thrombocytopenia—Octreotide—thymus cancer	0.000688	0.00768	CcSEcCtD
Pazopanib—FGF1—pituitary gland—thymus cancer	0.000685	0.00495	CbGeAlD
Pazopanib—PI4KB—lung—thymus cancer	0.000684	0.00494	CbGeAlD
Pazopanib—KDR—hematopoietic system—thymus cancer	0.000683	0.00494	CbGeAlD
Pazopanib—Skin disorder—Octreotide—thymus cancer	0.000682	0.00762	CcSEcCtD
Pazopanib—Hyperhidrosis—Octreotide—thymus cancer	0.000679	0.00758	CcSEcCtD
Pazopanib—LIMK2—lung—thymus cancer	0.000672	0.00485	CbGeAlD
Pazopanib—TAOK1—lymph node—thymus cancer	0.000671	0.00485	CbGeAlD
Pazopanib—Anorexia—Octreotide—thymus cancer	0.00067	0.00748	CcSEcCtD
Pazopanib—CSF1R—hematopoietic system—thymus cancer	0.000667	0.00482	CbGeAlD
Pazopanib—FLT4—bone marrow—thymus cancer	0.000666	0.00481	CbGeAlD
Pazopanib—FLT4—thyroid gland—thymus cancer	0.000665	0.0048	CbGeAlD
Pazopanib—PIP4K2C—bone marrow—thymus cancer	0.000663	0.00479	CbGeAlD
Pazopanib—PIP4K2C—thyroid gland—thymus cancer	0.000661	0.00478	CbGeAlD
Pazopanib—FGFR1—thyroid gland—thymus cancer	0.000656	0.00474	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—thymus cancer	0.00065	0.0047	CbGeAlD
Pazopanib—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00064	0.00715	CcSEcCtD
Pazopanib—Insomnia—Octreotide—thymus cancer	0.000635	0.00709	CcSEcCtD
Pazopanib—SH2B3—lymph node—thymus cancer	0.000632	0.00457	CbGeAlD
Pazopanib—Paraesthesia—Octreotide—thymus cancer	0.000631	0.00704	CcSEcCtD
Pazopanib—MAP3K2—bone marrow—thymus cancer	0.000628	0.00454	CbGeAlD
Pazopanib—MAP3K2—thyroid gland—thymus cancer	0.000627	0.00453	CbGeAlD
Pazopanib—Dyspnoea—Octreotide—thymus cancer	0.000626	0.00699	CcSEcCtD
Pazopanib—Somnolence—Octreotide—thymus cancer	0.000625	0.00697	CcSEcCtD
Pazopanib—KDR—epithelium—thymus cancer	0.000624	0.00451	CbGeAlD
Pazopanib—AURKC—lymph node—thymus cancer	0.000622	0.0045	CbGeAlD
Pazopanib—Dyspepsia—Octreotide—thymus cancer	0.000618	0.0069	CcSEcCtD
Pazopanib—FLT1—cardiac atrium—thymus cancer	0.000614	0.00443	CbGeAlD
Pazopanib—Decreased appetite—Octreotide—thymus cancer	0.000611	0.00682	CcSEcCtD
Pazopanib—EPHB6—cardiac atrium—thymus cancer	0.000607	0.00438	CbGeAlD
Pazopanib—Gastrointestinal disorder—Octreotide—thymus cancer	0.000606	0.00677	CcSEcCtD
Pazopanib—Fatigue—Octreotide—thymus cancer	0.000606	0.00676	CcSEcCtD
Pazopanib—KIT—hematopoietic system—thymus cancer	0.000605	0.00437	CbGeAlD
Pazopanib—FLT4—lung—thymus cancer	0.000604	0.00436	CbGeAlD
Pazopanib—SLCO1B1—hematopoietic system—thymus cancer	0.000601	0.00434	CbGeAlD
Pazopanib—Pain—Octreotide—thymus cancer	0.000601	0.00671	CcSEcCtD
Pazopanib—PIP4K2C—lung—thymus cancer	0.0006	0.00434	CbGeAlD
Pazopanib—FLT1—pituitary gland—thymus cancer	0.000599	0.00433	CbGeAlD
Pazopanib—FGFR1—lung—thymus cancer	0.000595	0.0043	CbGeAlD
Pazopanib—EPHB6—pituitary gland—thymus cancer	0.000592	0.00428	CbGeAlD
Pazopanib—PDGFRB—hematopoietic system—thymus cancer	0.000591	0.00427	CbGeAlD
Pazopanib—FGF1—thyroid gland—thymus cancer	0.00059	0.00427	CbGeAlD
Pazopanib—LCK—bone marrow—thymus cancer	0.000588	0.00425	CbGeAlD
Pazopanib—LCK—thyroid gland—thymus cancer	0.000587	0.00424	CbGeAlD
Pazopanib—TAOK3—cardiac atrium—thymus cancer	0.000579	0.00418	CbGeAlD
Pazopanib—Gastrointestinal pain—Octreotide—thymus cancer	0.000574	0.00641	CcSEcCtD
Pazopanib—MAP3K2—lung—thymus cancer	0.000569	0.00411	CbGeAlD
Pazopanib—PLK4—lymph node—thymus cancer	0.000569	0.00411	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—thymus cancer	0.000569	0.00411	CbGeAlD
Pazopanib—TAOK3—pituitary gland—thymus cancer	0.000565	0.00408	CbGeAlD
Pazopanib—FGFR2—thyroid gland—thymus cancer	0.000557	0.00403	CbGeAlD
Pazopanib—Abdominal pain—Octreotide—thymus cancer	0.000555	0.0062	CcSEcCtD
Pazopanib—KIT—epithelium—thymus cancer	0.000553	0.004	CbGeAlD
Pazopanib—PDGFRB—epithelium—thymus cancer	0.00054	0.00391	CbGeAlD
Pazopanib—STK10—lymphoid tissue—thymus cancer	0.000539	0.00389	CbGeAlD
Pazopanib—STK16—lymph node—thymus cancer	0.000537	0.00388	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—thymus cancer	0.000536	0.00388	CbGeAlD
Pazopanib—FGF1—lung—thymus cancer	0.000536	0.00387	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—thymus cancer	0.000533	0.00385	CbGeAlD
Pazopanib—LCK—lung—thymus cancer	0.000533	0.00385	CbGeAlD
Pazopanib—RIOK2—lymph node—thymus cancer	0.000529	0.00382	CbGeAlD
Pazopanib—BMPR1B—lymph node—thymus cancer	0.000524	0.00378	CbGeAlD
Pazopanib—KDR—cardiac atrium—thymus cancer	0.000519	0.00375	CbGeAlD
Pazopanib—MAP2K5—cardiac atrium—thymus cancer	0.000519	0.00375	CbGeAlD
Pazopanib—FLT1—thyroid gland—thymus cancer	0.000517	0.00373	CbGeAlD
Pazopanib—EPHB6—thyroid gland—thymus cancer	0.000511	0.00369	CbGeAlD
Pazopanib—KDR—pituitary gland—thymus cancer	0.000507	0.00366	CbGeAlD
Pazopanib—MAP2K5—pituitary gland—thymus cancer	0.000507	0.00366	CbGeAlD
Pazopanib—FGFR2—lung—thymus cancer	0.000506	0.00366	CbGeAlD
Pazopanib—CSF1R—cardiac atrium—thymus cancer	0.000506	0.00366	CbGeAlD
Pazopanib—Asthenia—Octreotide—thymus cancer	0.000504	0.00563	CcSEcCtD
Pazopanib—Pruritus—Octreotide—thymus cancer	0.000497	0.00555	CcSEcCtD
Pazopanib—CSF1R—pituitary gland—thymus cancer	0.000494	0.00357	CbGeAlD
Pazopanib—STK10—bone marrow—thymus cancer	0.00049	0.00354	CbGeAlD
Pazopanib—STK10—thyroid gland—thymus cancer	0.000489	0.00353	CbGeAlD
Pazopanib—TAOK3—bone marrow—thymus cancer	0.000488	0.00353	CbGeAlD
Pazopanib—TAOK3—thyroid gland—thymus cancer	0.000487	0.00352	CbGeAlD
Pazopanib—PDGFRA—thyroid gland—thymus cancer	0.000484	0.0035	CbGeAlD
Pazopanib—KDR—lymphoid tissue—thymus cancer	0.000481	0.00348	CbGeAlD
Pazopanib—Diarrhoea—Octreotide—thymus cancer	0.000481	0.00537	CcSEcCtD
Pazopanib—STK36—lymph node—thymus cancer	0.000475	0.00343	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—thymus cancer	0.000469	0.00339	CbGeAlD
Pazopanib—FLT1—lung—thymus cancer	0.000469	0.00339	CbGeAlD
Pazopanib—PI4KB—lymph node—thymus cancer	0.000468	0.00338	CbGeAlD
Pazopanib—Dizziness—Octreotide—thymus cancer	0.000465	0.00519	CcSEcCtD
Pazopanib—EPHB6—lung—thymus cancer	0.000464	0.00335	CbGeAlD
Pazopanib—LIMK2—lymph node—thymus cancer	0.000459	0.00332	CbGeAlD
Pazopanib—KIT—pituitary gland—thymus cancer	0.000449	0.00324	CbGeAlD
Pazopanib—PDGFRB—cardiac atrium—thymus cancer	0.000449	0.00324	CbGeAlD
Pazopanib—Vomiting—Octreotide—thymus cancer	0.000447	0.00499	CcSEcCtD
Pazopanib—STK10—lung—thymus cancer	0.000444	0.00321	CbGeAlD
Pazopanib—Rash—Octreotide—thymus cancer	0.000443	0.00495	CcSEcCtD
Pazopanib—TAOK3—lung—thymus cancer	0.000443	0.0032	CbGeAlD
Pazopanib—Dermatitis—Octreotide—thymus cancer	0.000443	0.00494	CcSEcCtD
Pazopanib—Headache—Octreotide—thymus cancer	0.00044	0.00491	CcSEcCtD
Pazopanib—PDGFRA—lung—thymus cancer	0.00044	0.00318	CbGeAlD
Pazopanib—PDGFRB—pituitary gland—thymus cancer	0.000439	0.00317	CbGeAlD
Pazopanib—KDR—bone marrow—thymus cancer	0.000438	0.00316	CbGeAlD
Pazopanib—KDR—thyroid gland—thymus cancer	0.000437	0.00316	CbGeAlD
Pazopanib—MAP2K5—thyroid gland—thymus cancer	0.000437	0.00316	CbGeAlD
Pazopanib—CSF1R—bone marrow—thymus cancer	0.000427	0.00309	CbGeAlD
Pazopanib—CSF1R—thyroid gland—thymus cancer	0.000426	0.00308	CbGeAlD
Pazopanib—KIT—lymphoid tissue—thymus cancer	0.000426	0.00308	CbGeAlD
Pazopanib—Nausea—Octreotide—thymus cancer	0.000417	0.00466	CcSEcCtD
Pazopanib—PDGFRB—lymphoid tissue—thymus cancer	0.000416	0.00301	CbGeAlD
Pazopanib—FLT4—lymph node—thymus cancer	0.000413	0.00298	CbGeAlD
Pazopanib—PIP4K2C—lymph node—thymus cancer	0.000411	0.00297	CbGeAlD
Pazopanib—FGFR1—lymph node—thymus cancer	0.000407	0.00294	CbGeAlD
Pazopanib—KDR—lung—thymus cancer	0.000397	0.00287	CbGeAlD
Pazopanib—MAP2K5—lung—thymus cancer	0.000397	0.00287	CbGeAlD
Pazopanib—MAP3K2—lymph node—thymus cancer	0.000389	0.00281	CbGeAlD
Pazopanib—KIT—bone marrow—thymus cancer	0.000388	0.0028	CbGeAlD
Pazopanib—CSF1R—lung—thymus cancer	0.000387	0.0028	CbGeAlD
Pazopanib—KIT—thyroid gland—thymus cancer	0.000387	0.0028	CbGeAlD
Pazopanib—PDGFRB—bone marrow—thymus cancer	0.000379	0.00274	CbGeAlD
Pazopanib—PDGFRB—thyroid gland—thymus cancer	0.000378	0.00273	CbGeAlD
Pazopanib—FGF1—lymph node—thymus cancer	0.000367	0.00265	CbGeAlD
Pazopanib—LCK—lymph node—thymus cancer	0.000364	0.00263	CbGeAlD
Pazopanib—KIT—lung—thymus cancer	0.000352	0.00254	CbGeAlD
Pazopanib—PDGFRB—lung—thymus cancer	0.000343	0.00248	CbGeAlD
Pazopanib—CYP2C8—hematopoietic system—thymus cancer	0.000342	0.00247	CbGeAlD
Pazopanib—FLT1—lymph node—thymus cancer	0.000321	0.00232	CbGeAlD
Pazopanib—CYP1A2—hematopoietic system—thymus cancer	0.00032	0.00231	CbGeAlD
Pazopanib—EPHB6—lymph node—thymus cancer	0.000317	0.00229	CbGeAlD
Pazopanib—STK10—lymph node—thymus cancer	0.000304	0.0022	CbGeAlD
Pazopanib—TAOK3—lymph node—thymus cancer	0.000303	0.00219	CbGeAlD
Pazopanib—PDGFRA—lymph node—thymus cancer	0.000301	0.00217	CbGeAlD
Pazopanib—KDR—lymph node—thymus cancer	0.000271	0.00196	CbGeAlD
Pazopanib—MAP2K5—lymph node—thymus cancer	0.000271	0.00196	CbGeAlD
Pazopanib—CSF1R—lymph node—thymus cancer	0.000265	0.00191	CbGeAlD
Pazopanib—CYP2C8—pituitary gland—thymus cancer	0.000254	0.00183	CbGeAlD
Pazopanib—ABCG2—pituitary gland—thymus cancer	0.000246	0.00178	CbGeAlD
Pazopanib—KIT—lymph node—thymus cancer	0.00024	0.00174	CbGeAlD
Pazopanib—PDGFRB—lymph node—thymus cancer	0.000235	0.0017	CbGeAlD
Pazopanib—CYP3A4—hematopoietic system—thymus cancer	0.000231	0.00167	CbGeAlD
Pazopanib—CYP2D6—hematopoietic system—thymus cancer	0.000228	0.00165	CbGeAlD
Pazopanib—ABCG2—bone marrow—thymus cancer	0.000213	0.00154	CbGeAlD
Pazopanib—ABCG2—thyroid gland—thymus cancer	0.000212	0.00154	CbGeAlD
Pazopanib—CYP1A2—thyroid gland—thymus cancer	0.000205	0.00148	CbGeAlD
Pazopanib—ABCG2—lung—thymus cancer	0.000193	0.00139	CbGeAlD
Pazopanib—CYP1A2—lung—thymus cancer	0.000186	0.00134	CbGeAlD
Pazopanib—ABCB1—hematopoietic system—thymus cancer	0.000164	0.00118	CbGeAlD
Pazopanib—ABCB1—epithelium—thymus cancer	0.00015	0.00108	CbGeAlD
Pazopanib—ABCG2—lymph node—thymus cancer	0.000132	0.000954	CbGeAlD
Pazopanib—ABCB1—pituitary gland—thymus cancer	0.000122	0.000878	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—thymus cancer	0.000115	0.000834	CbGeAlD
Pazopanib—ABCB1—bone marrow—thymus cancer	0.000105	0.000759	CbGeAlD
Pazopanib—ABCB1—thyroid gland—thymus cancer	0.000105	0.000757	CbGeAlD
Pazopanib—ABCB1—lung—thymus cancer	9.52e-05	0.000688	CbGeAlD
Pazopanib—ABCB1—lymph node—thymus cancer	6.51e-05	0.00047	CbGeAlD
Pazopanib—PDGFRA—Signaling by EGFR in Cancer—AKT1—thymus cancer	3.93e-05	0.000406	CbGpPWpGaD
Pazopanib—EPHB6—Developmental Biology—AKT1—thymus cancer	3.92e-05	0.000406	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by PDGF—AKT1—thymus cancer	3.92e-05	0.000405	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—KIT—thymus cancer	3.92e-05	0.000405	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by PDGF—AKT1—thymus cancer	3.91e-05	0.000404	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—KIT—thymus cancer	3.91e-05	0.000404	CbGpPWpGaD
Pazopanib—KIT—B Cell Activation—AKT1—thymus cancer	3.91e-05	0.000404	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—CD4—thymus cancer	3.89e-05	0.000402	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signal transduction—AKT1—thymus cancer	3.89e-05	0.000402	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR—AKT1—thymus cancer	3.87e-05	0.0004	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by ERBB2—AKT1—thymus cancer	3.85e-05	0.000398	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 signaling—AKT1—thymus cancer	3.83e-05	0.000396	CbGpPWpGaD
Pazopanib—FGFR2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.81e-05	0.000394	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling by NGF—AKT1—thymus cancer	3.81e-05	0.000394	CbGpPWpGaD
Pazopanib—PDGFRA—Focal Adhesion—AKT1—thymus cancer	3.78e-05	0.000391	CbGpPWpGaD
Pazopanib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	3.77e-05	0.00039	CbGpPWpGaD
Pazopanib—FGFR1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.77e-05	0.00039	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD8A—thymus cancer	3.76e-05	0.000389	CbGpPWpGaD
Pazopanib—PDGFRA—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.76e-05	0.000389	CbGpPWpGaD
Pazopanib—PDGFRB—MAPK Signaling Pathway—AKT1—thymus cancer	3.76e-05	0.000388	CbGpPWpGaD
Pazopanib—KIT—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.74e-05	0.000387	CbGpPWpGaD
Pazopanib—FGFR1—B Cell Activation—AKT1—thymus cancer	3.71e-05	0.000384	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—KIT—thymus cancer	3.71e-05	0.000383	CbGpPWpGaD
Pazopanib—PDGFRA—B Cell Activation—AKT1—thymus cancer	3.7e-05	0.000383	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL2—thymus cancer	3.69e-05	0.000382	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—KIT—thymus cancer	3.67e-05	0.000379	CbGpPWpGaD
Pazopanib—PDGFRB—DAP12 interactions—AKT1—thymus cancer	3.6e-05	0.000372	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by FGFR in disease—AKT1—thymus cancer	3.6e-05	0.000372	CbGpPWpGaD
Pazopanib—PDGFRB—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	3.6e-05	0.000372	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—KIT—thymus cancer	3.59e-05	0.000371	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAML2—thymus cancer	3.57e-05	0.000369	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR—AKT1—thymus cancer	3.57e-05	0.000369	CbGpPWpGaD
Pazopanib—FGFR1—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.55e-05	0.000367	CbGpPWpGaD
Pazopanib—PDGFRA—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.54e-05	0.000366	CbGpPWpGaD
Pazopanib—FGF1—Signaling by NGF—AKT1—thymus cancer	3.54e-05	0.000366	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by EGFR in Cancer—AKT1—thymus cancer	3.54e-05	0.000366	CbGpPWpGaD
Pazopanib—LYN—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	3.53e-05	0.000365	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by PDGF—AKT1—thymus cancer	3.52e-05	0.000364	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—KIT—thymus cancer	3.52e-05	0.000364	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAML2—thymus cancer	3.51e-05	0.000363	CbGpPWpGaD
Pazopanib—LCK—Signaling by SCF-KIT—AKT1—thymus cancer	3.47e-05	0.000358	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—KIT—thymus cancer	3.45e-05	0.000356	CbGpPWpGaD
Pazopanib—LCK—Disease—MAML2—thymus cancer	3.43e-05	0.000354	CbGpPWpGaD
Pazopanib—FGFR3—Disease—KIT—thymus cancer	3.42e-05	0.000354	CbGpPWpGaD
Pazopanib—PDGFRB—Focal Adhesion—AKT1—thymus cancer	3.4e-05	0.000352	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD8A—thymus cancer	3.4e-05	0.000351	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—CD4—thymus cancer	3.35e-05	0.000346	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD8A—thymus cancer	3.34e-05	0.000345	CbGpPWpGaD
Pazopanib—PDGFRB—B Cell Activation—AKT1—thymus cancer	3.33e-05	0.000345	CbGpPWpGaD
Pazopanib—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	3.33e-05	0.000345	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAML2—thymus cancer	3.33e-05	0.000344	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAML2—thymus cancer	3.32e-05	0.000343	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling of activated FGFR—AKT1—thymus cancer	3.32e-05	0.000343	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—CD4—thymus cancer	3.29e-05	0.00034	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB4—AKT1—thymus cancer	3.26e-05	0.000338	CbGpPWpGaD
Pazopanib—LYN—B Cell Activation—AKT1—thymus cancer	3.26e-05	0.000337	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—IL2—thymus cancer	3.24e-05	0.000335	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—CD4—thymus cancer	3.22e-05	0.000332	CbGpPWpGaD
Pazopanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	3.19e-05	0.00033	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD8A—thymus cancer	3.17e-05	0.000327	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—CD4—thymus cancer	3.16e-05	0.000327	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD8A—thymus cancer	3.16e-05	0.000326	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—KIT—thymus cancer	3.14e-05	0.000325	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—CD4—thymus cancer	3.12e-05	0.000323	CbGpPWpGaD
Pazopanib—LCK—Downstream signal transduction—AKT1—thymus cancer	3.12e-05	0.000322	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—CD4—thymus cancer	3.11e-05	0.000322	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR—AKT1—thymus cancer	3.1e-05	0.000321	CbGpPWpGaD
Pazopanib—LCK—Signaling by ERBB2—AKT1—thymus cancer	3.09e-05	0.000319	CbGpPWpGaD
Pazopanib—FGF1—Immune System—KIT—thymus cancer	3.08e-05	0.000319	CbGpPWpGaD
Pazopanib—LCK—DAP12 signaling—AKT1—thymus cancer	3.07e-05	0.000318	CbGpPWpGaD
Pazopanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	3.03e-05	0.000313	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—TP53—thymus cancer	3e-05	0.00031	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—CD4—thymus cancer	3e-05	0.00031	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAML2—thymus cancer	2.99e-05	0.000309	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD4—thymus cancer	2.99e-05	0.000309	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL2—thymus cancer	2.96e-05	0.000306	CbGpPWpGaD
Pazopanib—LYN—Platelet activation, signaling and aggregation—AKT1—thymus cancer	2.95e-05	0.000305	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—KIT—thymus cancer	2.94e-05	0.000304	CbGpPWpGaD
Pazopanib—FGFR2—Signaling by NGF—AKT1—thymus cancer	2.93e-05	0.000303	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAML2—thymus cancer	2.93e-05	0.000303	CbGpPWpGaD
Pazopanib—LCK—Signaling by FGFR in disease—AKT1—thymus cancer	2.89e-05	0.000299	CbGpPWpGaD
Pazopanib—LCK—DAP12 interactions—AKT1—thymus cancer	2.89e-05	0.000299	CbGpPWpGaD
Pazopanib—LCK—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	2.89e-05	0.000299	CbGpPWpGaD
Pazopanib—KIT—Signaling by NGF—AKT1—thymus cancer	2.88e-05	0.000297	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR—AKT1—thymus cancer	2.86e-05	0.000296	CbGpPWpGaD
Pazopanib—FGF1—Disease—KIT—thymus cancer	2.85e-05	0.000294	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD8A—thymus cancer	2.84e-05	0.000294	CbGpPWpGaD
Pazopanib—LCK—Signaling by EGFR in Cancer—AKT1—thymus cancer	2.84e-05	0.000294	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD4—thymus cancer	2.84e-05	0.000293	CbGpPWpGaD
Pazopanib—LCK—Signaling by PDGF—AKT1—thymus cancer	2.83e-05	0.000292	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—KIT—thymus cancer	2.83e-05	0.000292	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—IL2—thymus cancer	2.81e-05	0.00029	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CD4—thymus cancer	2.8e-05	0.00029	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD8A—thymus cancer	2.78e-05	0.000288	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CD4—thymus cancer	2.75e-05	0.000284	CbGpPWpGaD
Pazopanib—FGFR1—Signaling by NGF—AKT1—thymus cancer	2.73e-05	0.000282	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling by NGF—AKT1—thymus cancer	2.72e-05	0.000282	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD4—thymus cancer	2.69e-05	0.000278	CbGpPWpGaD
Pazopanib—LCK—B Cell Activation—AKT1—thymus cancer	2.67e-05	0.000277	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD4—thymus cancer	2.64e-05	0.000273	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CD4—thymus cancer	2.62e-05	0.000271	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL2—thymus cancer	2.61e-05	0.00027	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—AKT1—thymus cancer	2.58e-05	0.000266	CbGpPWpGaD
Pazopanib—LCK—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	2.56e-05	0.000265	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—KIT—thymus cancer	2.55e-05	0.000264	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—AKT1—thymus cancer	2.53e-05	0.000262	CbGpPWpGaD
Pazopanib—ITK—Immune System—AKT1—thymus cancer	2.52e-05	0.000261	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—AKT1—thymus cancer	2.45e-05	0.000254	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—AKT1—thymus cancer	2.43e-05	0.000251	CbGpPWpGaD
Pazopanib—LCK—Platelet activation, signaling and aggregation—AKT1—thymus cancer	2.42e-05	0.00025	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAML2—thymus cancer	2.4e-05	0.000248	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—KIT—thymus cancer	2.4e-05	0.000248	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—AKT1—thymus cancer	2.4e-05	0.000248	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—KIT—thymus cancer	2.38e-05	0.000246	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—KIT—thymus cancer	2.37e-05	0.000245	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD4—thymus cancer	2.36e-05	0.000244	CbGpPWpGaD
Pazopanib—FGFR2—Disease—KIT—thymus cancer	2.35e-05	0.000243	CbGpPWpGaD
Pazopanib—FGFR3—Adaptive Immune System—AKT1—thymus cancer	2.33e-05	0.000241	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IL2—thymus cancer	2.3e-05	0.000238	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD8A—thymus cancer	2.28e-05	0.000236	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD4—thymus cancer	2.25e-05	0.000233	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL2—thymus cancer	2.21e-05	0.000228	CbGpPWpGaD
Pazopanib—FGFR1—Disease—KIT—thymus cancer	2.19e-05	0.000227	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—KIT—thymus cancer	2.19e-05	0.000226	CbGpPWpGaD
Pazopanib—FGF1—Disease—CD4—thymus cancer	2.18e-05	0.000225	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL2—thymus cancer	2.17e-05	0.000224	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD4—thymus cancer	2.16e-05	0.000223	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KIT—thymus cancer	2.14e-05	0.000222	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—KIT—thymus cancer	2.14e-05	0.000221	CbGpPWpGaD
Pazopanib—LYN—Immune System—KIT—thymus cancer	2.09e-05	0.000216	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—KIT—thymus cancer	2.09e-05	0.000216	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—TP53—thymus cancer	2.08e-05	0.000215	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—AKT1—thymus cancer	2.02e-05	0.000209	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KIT—thymus cancer	1.99e-05	0.000206	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—KIT—thymus cancer	1.97e-05	0.000204	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—AKT1—thymus cancer	1.97e-05	0.000204	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD4—thymus cancer	1.95e-05	0.000202	CbGpPWpGaD
Pazopanib—FGF1—Adaptive Immune System—AKT1—thymus cancer	1.94e-05	0.0002	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD4—thymus cancer	1.92e-05	0.000198	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—TP53—thymus cancer	1.9e-05	0.000197	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD4—thymus cancer	1.82e-05	0.000188	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—thymus cancer	1.81e-05	0.000187	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—TP53—thymus cancer	1.8e-05	0.000186	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—thymus cancer	1.8e-05	0.000186	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2—thymus cancer	1.79e-05	0.000186	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—thymus cancer	1.77e-05	0.000183	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—AKT1—thymus cancer	1.76e-05	0.000182	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2—thymus cancer	1.76e-05	0.000182	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—AKT1—thymus cancer	1.76e-05	0.000181	CbGpPWpGaD
Pazopanib—LCK—Immune System—KIT—thymus cancer	1.71e-05	0.000177	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—thymus cancer	1.69e-05	0.000174	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	1.69e-05	0.000174	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—thymus cancer	1.68e-05	0.000174	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—thymus cancer	1.67e-05	0.000173	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—thymus cancer	1.67e-05	0.000173	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—AKT1—thymus cancer	1.67e-05	0.000173	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—thymus cancer	1.67e-05	0.000173	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KIT—thymus cancer	1.65e-05	0.00017	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—AKT1—thymus cancer	1.64e-05	0.00017	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—thymus cancer	1.63e-05	0.000169	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—AKT1—thymus cancer	1.61e-05	0.000166	CbGpPWpGaD
Pazopanib—FGFR2—Adaptive Immune System—AKT1—thymus cancer	1.6e-05	0.000166	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—thymus cancer	1.6e-05	0.000165	CbGpPWpGaD
Pazopanib—LCK—Disease—KIT—thymus cancer	1.58e-05	0.000164	CbGpPWpGaD
Pazopanib—KIT—Adaptive Immune System—AKT1—thymus cancer	1.58e-05	0.000163	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—AKT1—thymus cancer	1.56e-05	0.000161	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—AKT1—thymus cancer	1.55e-05	0.000161	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—AKT1—thymus cancer	1.55e-05	0.00016	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KIT—thymus cancer	1.54e-05	0.000159	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KIT—thymus cancer	1.53e-05	0.000158	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—AKT1—thymus cancer	1.52e-05	0.000157	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—thymus cancer	1.51e-05	0.000156	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—thymus cancer	1.51e-05	0.000156	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—thymus cancer	1.5e-05	0.000155	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—AKT1—thymus cancer	1.5e-05	0.000155	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—AKT1—thymus cancer	1.49e-05	0.000154	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—thymus cancer	1.48e-05	0.000153	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—thymus cancer	1.47e-05	0.000152	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—thymus cancer	1.47e-05	0.000152	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	1.42e-05	0.000147	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—thymus cancer	1.42e-05	0.000147	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—AKT1—thymus cancer	1.41e-05	0.000146	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—thymus cancer	1.4e-05	0.000145	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—AKT1—thymus cancer	1.4e-05	0.000145	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KIT—thymus cancer	1.38e-05	0.000143	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—AKT1—thymus cancer	1.37e-05	0.000142	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KIT—thymus cancer	1.35e-05	0.00014	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—AKT1—thymus cancer	1.34e-05	0.000139	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—AKT1—thymus cancer	1.32e-05	0.000136	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—thymus cancer	1.31e-05	0.000136	CbGpPWpGaD
Pazopanib—FGFR3—Disease—AKT1—thymus cancer	1.31e-05	0.000135	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—AKT1—thymus cancer	1.25e-05	0.000129	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—thymus cancer	1.21e-05	0.000125	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—thymus cancer	1.21e-05	0.000125	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—AKT1—thymus cancer	1.2e-05	0.000124	CbGpPWpGaD
Pazopanib—FGF1—Immune System—AKT1—thymus cancer	1.18e-05	0.000122	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—thymus cancer	1.16e-05	0.00012	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—thymus cancer	1.14e-05	0.000118	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—AKT1—thymus cancer	1.12e-05	0.000116	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KIT—thymus cancer	1.11e-05	0.000115	CbGpPWpGaD
Pazopanib—FGF1—Disease—AKT1—thymus cancer	1.09e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—thymus cancer	1.08e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—thymus cancer	1.08e-05	0.000112	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—thymus cancer	1.08e-05	0.000112	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—AKT1—thymus cancer	1.08e-05	0.000111	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—AKT1—thymus cancer	9.73e-06	0.000101	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—thymus cancer	9.72e-06	0.0001	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—thymus cancer	9.68e-06	0.0001	CbGpPWpGaD
Pazopanib—KIT—Immune System—AKT1—thymus cancer	9.56e-06	9.88e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—thymus cancer	9.51e-06	9.84e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—thymus cancer	9.44e-06	9.76e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AKT1—thymus cancer	9.15e-06	9.46e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—AKT1—thymus cancer	9.07e-06	9.38e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—AKT1—thymus cancer	9.05e-06	9.35e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—thymus cancer	9e-06	9.31e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—AKT1—thymus cancer	8.98e-06	9.29e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—AKT1—thymus cancer	8.82e-06	9.12e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—AKT1—thymus cancer	8.37e-06	8.66e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—AKT1—thymus cancer	8.35e-06	8.64e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AKT1—thymus cancer	8.18e-06	8.46e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—AKT1—thymus cancer	8.15e-06	8.43e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—AKT1—thymus cancer	7.98e-06	8.25e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AKT1—thymus cancer	7.97e-06	8.24e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—thymus cancer	7.8e-06	8.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AKT1—thymus cancer	7.6e-06	7.86e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—AKT1—thymus cancer	7.53e-06	7.78e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—thymus cancer	7.45e-06	7.7e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—thymus cancer	7.32e-06	7.57e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—thymus cancer	6.94e-06	7.18e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—thymus cancer	6.93e-06	7.16e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—AKT1—thymus cancer	6.54e-06	6.76e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AKT1—thymus cancer	6.29e-06	6.51e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—thymus cancer	6.24e-06	6.45e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AKT1—thymus cancer	6.18e-06	6.39e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—thymus cancer	6.11e-06	6.32e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—AKT1—thymus cancer	6.04e-06	6.24e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AKT1—thymus cancer	5.86e-06	6.06e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AKT1—thymus cancer	5.85e-06	6.05e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—AKT1—thymus cancer	5.77e-06	5.97e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—AKT1—thymus cancer	5.29e-06	5.47e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AKT1—thymus cancer	5.27e-06	5.45e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AKT1—thymus cancer	5.16e-06	5.33e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—thymus cancer	5.01e-06	5.18e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—AKT1—thymus cancer	4.9e-06	5.07e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AKT1—thymus cancer	4.23e-06	4.37e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—AKT1—thymus cancer	3.04e-06	3.14e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—AKT1—thymus cancer	2.65e-06	2.74e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—AKT1—thymus cancer	2.5e-06	2.58e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—AKT1—thymus cancer	2.11e-06	2.19e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—AKT1—thymus cancer	1.63e-06	1.69e-05	CbGpPWpGaD
